Access to β-acetoxyselenides, perhydroindolones and anticancer piperidinones via blue LED-driven selenylation of unsaturated carboxamides

Read full text Summarise with VIRAT
Authors: Alla I. Vaskevych, Natalia Maciejewska, Anastasiia Mysiak, Svitlana Valentinovna Shishkina, Marina L. Dekhtyar, Maryna Stasevych, M. B. Vovk
Cited by: 0
References: 107

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Blue LED-initiated selenylation of unsaturated acid amides with diorganyl diselenides in acetic and formic acids was shown to proceed either through a three-component conjugate addition to the double C=C bond, or via selenocyclization, depending on the N-substituent and solvent. The latter occurs as O-cyclization via the exo-trig mode to give iminolactones/lactones or as N-cyclization via the 5-exo-trig and 6-endo-trig modes to give selenyl-functionalized perhydroindolones and piperidinones, respectively. Among the synthesized compounds, the piperidinone derivative 12ea exhibited the greatest antiproliferative potency in human cervical carcinoma (HeLa) and human colorectal carcinoma (HCT-116) cells, with half-maximal inhibitory concentration (IC50) values in the micromolar range. Mechanistic studies revealed induction of apoptosis, confirmed by caspase-3/7 activation, Annexin V/propidium iodide staining, and nuclear abnormalities with γH2AX foci, consistent with DNA damage and mitotic stress. In three-dimensional spheroid models, 12ea effectively suppressed tumor-like growth and promoted apoptotic cell death. These findings identify 12ea as a promising and selective lead compound for further development in anticancer drug discovery.

Fields of Study & Subjects

Organoselenium and organotellurium chemistry Sulfur-Based Synthesis Techniques Radical Photochemical Reactions

Publication details

Journal / source
Scientific Reports
Volume
16
Issue
1
Publication date
25 March 2026
Language
EN